Posters

Academic Level (Author 1)

Medical Student

Discipline/Specialty (Author 1)

Medical Education

Academic Level (Author 2)

Medical Student

Discipline/Specialty (Author 2)

Medical Education

Academic Level (Author 3)

Medical Student

Discipline/Specialty (Author 3)

Medical Education

Academic Level (Author 4)

Medical Student

Discipline/Specialty (Author 4)

Medical Education

Academic Level (Author 5)

Medical Student

Discipline/Specialty (Author 5)

Medical Education

Academic Level (Author 6)

Medical Student

Discipline/Specialty (Author 6)

Medical Education

Academic Level (Author 7)

Medical Student

Discipline/Specialty (Author 7)

Medical Education

Academic Level (Author 8)

Medical Student

Discipline/Specialty (Author 8)

Medical Education

Academic Level (Author 9)

Medical Student

Discipline/Specialty (Author 9)

Medical Education

Academic Level (Author 10)

Medical Student

Discipline/Specialty (Author 10)

Medical Education

Discipline Track

Biomedical Science

Abstract

Background: The synuclein deposition in the brain of Parkinson’s Disease (PD) is the hallmark pathology of the neurodegenerative pathway. The transformation of alpha-synuclein into synuclein monomer, toxic oligomer, and insoluble fibrils are key steps in cell dysfunction. We synthesized a novel molecule, Curcumin-glucoside (Curc-gluc), which has good water solubility and a favorable partition coefficient.

Methods: The present study focuses on α-syn aggregation kinetics in the presence and absence of Curc-gluc and Curcumin; we also tested the effect of Copper (Cu) and Iron (Fe) Fe binding through a mathematical approach, biophysical techniques, and docking models. In the mathematical approach, we applied mathematical analyses such as self-association kinetics. In biophysical studies, we used circular dichroism and thioflavin studies. For docking model studies, we employed a two-step computational approach, including ligand pocket analysis and molecular docking simulations.

Results: The results indicated that Curc-gluc effectively prevents aggregation better than Curcumin alone and effectively prevents Cu and Fe-induced aggregation of α-syn. Curc-gluc favored α-helix formation and reduced β-formation, thus preventing α-syn aggregation. Docking studies indicated that Curc-gluc derivatives interacted with various chains of α-syn fibrils, namely G-chain, A-chain, I-chain, and E-chain. The interaction data showed that Curcumin Di-Glucoside tetraacetate has the most favorable binding affinity with α-syn fibrils, with -CDOCKER ENERGY of 60.7222 kcal/mol and -CDOCKER INTERACTION ENERGY of 89.6516 kcal/mol. It could form strong hydrogen bond interactions with core functional amino acids such as GLU61, THR72, GLY73, GLU57, THR59, and VAL74. The compounds also exhibit Pi–Pi interaction.

Conclusion: These studies indicate the potential of Curc-gluc as a future drug for the clinical management of PD.

Presentation Type

Poster

Download

Share

COinS
 

Molecular studies in understanding Novel Curcumin-Glucoside role in the prevention of Alpha-Synuclein aggregation in relevance to Parkinson's Disease

Background: The synuclein deposition in the brain of Parkinson’s Disease (PD) is the hallmark pathology of the neurodegenerative pathway. The transformation of alpha-synuclein into synuclein monomer, toxic oligomer, and insoluble fibrils are key steps in cell dysfunction. We synthesized a novel molecule, Curcumin-glucoside (Curc-gluc), which has good water solubility and a favorable partition coefficient.

Methods: The present study focuses on α-syn aggregation kinetics in the presence and absence of Curc-gluc and Curcumin; we also tested the effect of Copper (Cu) and Iron (Fe) Fe binding through a mathematical approach, biophysical techniques, and docking models. In the mathematical approach, we applied mathematical analyses such as self-association kinetics. In biophysical studies, we used circular dichroism and thioflavin studies. For docking model studies, we employed a two-step computational approach, including ligand pocket analysis and molecular docking simulations.

Results: The results indicated that Curc-gluc effectively prevents aggregation better than Curcumin alone and effectively prevents Cu and Fe-induced aggregation of α-syn. Curc-gluc favored α-helix formation and reduced β-formation, thus preventing α-syn aggregation. Docking studies indicated that Curc-gluc derivatives interacted with various chains of α-syn fibrils, namely G-chain, A-chain, I-chain, and E-chain. The interaction data showed that Curcumin Di-Glucoside tetraacetate has the most favorable binding affinity with α-syn fibrils, with -CDOCKER ENERGY of 60.7222 kcal/mol and -CDOCKER INTERACTION ENERGY of 89.6516 kcal/mol. It could form strong hydrogen bond interactions with core functional amino acids such as GLU61, THR72, GLY73, GLU57, THR59, and VAL74. The compounds also exhibit Pi–Pi interaction.

Conclusion: These studies indicate the potential of Curc-gluc as a future drug for the clinical management of PD.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.